STUDY/PROTOCOL TITLE AND PROTOCOL NUMBER: "A Phase II, Open-label Randomized Study of Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men with High Risk Prostate Cancer"; XL184-IST64